News
Important Only
Health insurers to work on easing prior authorization requirements, AHIP says
June 23 (Reuters) - America's Health Insurance Plans said on Monday that U.S. health insurers will take additional measures to simplify their requirements for prior approval on medicines and medical services. Health insurers will work to develop standardized data and submission requiremen...Reuters
Mon, Jun 23
Forte Biosciences Announces Positive Data In Fb102 Celiac Disease Phase 1B Study
June 23 (Reuters) - Forte Biosciences Inc FBRX.O:FORTE BIOSCIENCES ANNOUNCES POSITIVE DATA IN FB102 CELIAC DISEASE PHASE 1B STUDYFORTE BIOSCIENCES INC - FB102 SHOWS SIGNIFICANT BENEFIT ON VCIEL ENDPOINTFORTE BIOSCIENCES INC - FB102 SHOWS DECLINE IN CD3-POSITIVE T CELLS DENSITYReuters
Mon, Jun 23
Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
June 23 (Reuters) - Illumina Inc ILMN.O:ILLUMINA TO ACQUIRE SOMALOGIC, ACCELERATING ITS PROTEOMICS BUSINESS AND ADVANCING THE COMPANY'S MULTIOMICS STRATEGYILLUMINA INC - TO BUY SOMALOGIC FOR $350 MILLION PLUS $75 MILLION IN MILESTONESILLUMINA INC - EXPECTS SOMALOGIC BUSINESS TO BE PROFITABLE IN ...Reuters
Mon, Jun 23
ADVISORY-Alert wrongly tagged to Kinco Automation Shanghai withdrawn
An alert on protective apparel maker Mechanix Wear acquiring family-owned glove maker Kinco was incorrectly tagged to Kinco Automation Shanghai Co Ltd 688160.SS, an unrelated company, and has been withdrawn.There will be no substitute.STORY_NUMBER: nTUA5PWDS8STORY_DATE: 23/06/2025 STORY_TIME: 1100 G...Reuters
Mon, Jun 23
Passage Bio Reports Updated Interim Data From Uplift-D Study
June 23 (Reuters) - Passage Bio Inc PASG.O:PASSAGE BIO REPORTS UPDATED INTERIM DATA FROM UPLIFT-D STUDY AND PROVIDES PROGRAM UPDATEPASSAGE BIO INC - DOSE 1 PBFT02 SHOWS DURABLE INCREASE IN CSF PGRN LEVELSPASSAGE BIO INC -REMAIN ON TRACK TO SEEK REGULATORY FEEDBACK ON FTD-GRN PIVOTAL TRIAL DESIGN IN ...Reuters
Mon, Jun 23
Supermicro Announces Proposed Offering Of $2.0 Billion Of Convertible Senior Notes Due 2030
June 23 (Reuters) - Super Micro Computer Inc SMCI.O:SUPERMICRO ANNOUNCES PROPOSED OFFERING OF $2.0 BILLION OF CONVERTIBLE SENIOR NOTES DUE 2030SUPERMICRO ANNOUNCES PROPOSED OFFERING OF $2.0 BILLION OF CONVERTIBLE SENIOR NOTES DUE 2030SUPER MICRO COMPUTER INC - SUPERMICRO MAY GRANT OPTION TO PURCHASE...Reuters
Mon, Jun 23
Sephience™ (Sepiapterin) Granted Marketing Authorization By The European Commission
June 23 (Reuters) - PTC Therapeutics Inc PTCT.O:SEPHIENCE™ (SEPIAPTERIN) GRANTED MARKETING AUTHORIZATION BY THE EUROPEAN COMMISSION FOR THE TREATMENT OF CHILDREN AND ADULTS LIVING WITH PHENYLKETONURIA (PKU)Reuters
Mon, Jun 23
Larimar Therapeutics Announces FDA Recommendations On Safety Database
June 23 (Reuters) - Larimar Therapeutics Inc LRMR.O:LARIMAR THERAPEUTICS ANNOUNCES FDA RECOMMENDATIONS ON SAFETY DATABASE, AND OTHER DETAILS OF NOMLABOFUSP BLA SUBMISSION FOR FRIEDREICH’S ATAXIA PROGRAMLARIMAR THERAPEUTICS INC - BLA SUBMISSION FOR ACCELERATED APPROVAL PLANNED IN Q2 2026LARIMAR THERA...Reuters
Mon, Jun 23
United Therapeutics Corporation Concludes Enrollment Of The Advance Outcomes Study Of Ralinepag
June 23 (Reuters) - United Therapeutics Corp UTHR.O:UNITED THERAPEUTICS CORPORATION CONCLUDES ENROLLMENT OF THE ADVANCE OUTCOMES STUDY OF RALINEPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONUNITED THERAPEUTICS CORP - ADVANCE OUTCOMES WILL CONTINUE TO ACCRUE CLINICAL WORSENING EVENTS THROUG...Reuters
Mon, Jun 23
